Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.

Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR Jr, Vazquez DM.

J Perinatol. 2005 Sep;25(9):595-604.

PMID:
16015372
2.

[Use of SSRIs during pregnancy and possible consequences for the development of the child].

van der Veere CN, Bos AF.

Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2873-4. Dutch.

PMID:
18257430
3.

Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.

Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.

Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. doi: 10.1136/archdischild-2011-214239. Review. Erratum in: Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F180.

PMID:
23080479
4.

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.

Zeskind PS, Stephens LE.

Pediatrics. 2004 Feb;113(2):368-75.

PMID:
14754951
5.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
6.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
7.

Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.

Koren G, Boucher N.

Can J Clin Pharmacol. 2009 Winter;16(1):e66-7. Epub 2009 Jan 22. Review.

PMID:
19164848
8.

Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: a review.

Fleschler R, Peskin MF.

MCN Am J Matern Child Nurs. 2008 Nov-Dec;33(6):355-61; quiz 362-3. doi: 10.1097/01.NMC.0000341255.80426.7b. Review.

PMID:
18997570
9.

Fetal and neonatal effects of maternal drug treatment for depression.

Belik J.

Semin Perinatol. 2008 Oct;32(5):350-4. doi: 10.1053/j.semperi.2008.08.001. Review.

PMID:
18929158
10.

Problems associated with long-term treatment with selective serotonin reuptake inhibitors.

Moret C, Isaac M, Briley M.

J Psychopharmacol. 2009 Nov;23(8):967-74. doi: 10.1177/0269881108093582. Epub 2008 Jul 17. Review.

PMID:
18635702
11.
12.

SSRI antidepressants and persistent pulmonary hypertension in newborns.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):156.

PMID:
19492488
13.

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.

N Engl J Med. 2006 Feb 9;354(6):579-87.

14.

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Merlob P.

Isr J Psychiatry Relat Sci. 2008;45(2):107-13. Review.

15.

New perspectives on the neurodevelopmental effects of SSRIs.

Homberg JR, Schubert D, Gaspar P.

Trends Pharmacol Sci. 2010 Feb;31(2):60-5. doi: 10.1016/j.tips.2009.11.003. Epub 2009 Dec 4.

PMID:
19963284
17.

Prenatal SSRI exposure: Effects on later child development.

Hermansen TK, Melinder A.

Child Neuropsychol. 2015;21(5):543-69. doi: 10.1080/09297049.2014.942727. Epub 2014 Aug 4.

PMID:
25089614
18.

[SSRI during pregnancy and risk of fetal neurotoxicity. Follow precautions and look for other therapeutic alternatives].

Högberg U, Wang M.

Lakartidningen. 2005 Jan 17-23;102(3):113-5. Review. Swedish.

PMID:
15712734
19.

Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels.

Knoppert DC, Nimkar R, Principi T, Yuen D.

Ther Drug Monit. 2006 Feb;28(1):5-7.

PMID:
16418684
20.

ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.

ACOG Committee on Obstetric Practice.

Obstet Gynecol. 2006 Dec;108(6):1601-3.

PMID:
17138801

Supplemental Content

Support Center